Related Experiment Videos
Ataxia-telangiectasia in a child with vaccine-associated paralytic poliomyelitis
K R Pohl1, J D Farley, J E Jan
1Department of Neurology, University of British Columbia, Vancouver, Canada.
The Journal of Pediatrics
|September 1, 1992
Insights
Vaccine-derived poliovirus caused poliomyelitis in an unvaccinated boy. Patients with ataxia-telangiectasia may face risks from live vaccines, necessitating immunity assessments.
Area of Science:
- Immunology
- Virology
- Genetics
Background:
- Poliomyelitis is a severe infectious disease preventable by vaccination.
- Live-attenuated vaccines are a common method for polio prevention.
- Ataxia-telangiectasia is a rare, inherited disorder affecting multiple body systems.
Observation:
- A 10-month-old boy, who was not immunized, developed vaccine-acquired poliomyelitis.
- The child was later diagnosed with ataxia-telangiectasia at age 4 years.
- This case highlights a potential complication in immunocompromised individuals.
Findings:
- The occurrence of vaccine-related poliomyelitis underscores the need for thorough immunity evaluation.
- Live vaccines pose potential hazards for patients diagnosed with ataxia-telangiectasia.
- Risk exists even when immune function appears normal.
Implications:
- Clinicians should carefully assess patient immunity before administering live vaccines.
- Consideration of underlying genetic disorders like ataxia-telangiectasia is crucial in vaccine safety.
- This case informs guidelines for vaccine use in vulnerable populations.
Abstract:
Vaccine-acquired poliomyelitis developed in a nonimmunized 10-month-old boy. At age 4 years, ataxia-telangiectasia was recognized. We conclude that the occurrence of vaccine-related poliomyelitis warrants a detailed assessment of immunity, and that, in patients with ataxia-telangiectasia, the use of live vaccines may be hazardous, even in those with apparently normal immunity.